Quick Heal Technologies Limited has released the transcript of its investor and analyst call for the fourth quarter and financial year 2026. The conference call was originally held on Friday, May 22, 2026, at 4:00 PM IST to discuss the company's financial results. The transcript document is now available for stakeholders to review the detailed discussion regarding quarterly and annual performance.

Access Details

The transcript is hosted on the Quick Heal Technologies investor relations page. Interested stakeholders can access the PDF document to review the management's commentary on the financial results.

Regulatory Filing

The intimation regarding the availability of the call transcript was submitted to the stock exchanges on May 28, 2026. The filing was made in compliance with Regulation 30 and was signed by Vikram Dhanani, Compliance Officer of Quick Heal Technologies Limited. The reference number for this correspondence is QHTL/Sec/SE/2026-27/11.

Quick Heal Technologies Limited has confirmed full compliance with the Securities and Exchange Board of India (SEBI) regulations for the financial year ended March 31, 2026. A secretarial compliance report filed by Ruchi Bhave, a Practicing Company Secretary, verified that the listed entity adhered to all relevant provisions, including the SEBI Act, 1992, and the Securities Contracts (Regulation) Act, 1956. The review covered various regulations such as the Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, and the Prohibition of Insider Trading Regulations, 2015.

The audit revealed no deviations or non-compliances during the review period. Specifically, the report noted that there were no instances of non-compliance regarding secretarial standards, the adoption and timely updation of policies, or the maintenance and disclosure of information on the company's website. Additionally, no directors were disqualified under Section 164 of the Companies Act, 2013.

Compliance Status and Key Findings

The report detailed the company's adherence to several governance and operational mandates. Quick Heal Technologies confirmed that it does not have any material subsidiaries as of March 31, 2026. The entity also maintained records as prescribed under SEBI regulations and conducted performance evaluations for the Board, Independent Directors, and Committees at the start of the financial year.

Regulatory Actions and Auditor Updates

The certification confirmed that no actions were taken by SEBI or Stock Exchanges against the listed entity, its promoters, directors, or subsidiaries during the review period. Regarding statutory auditors, the report noted that while there were no resignations, the firm M S K A & Associates converted into a Limited Liability Partnership named M S K A & Associates LLP effective January 13, 2026.

The company also complied with disclosure requirements for Employee Benefit Scheme Documents under Regulation 46(2)(za) of the SEBI (LODR) Regulations, 2015. The report emphasized that the responsibility for compliance and authenticity of documents lies with the management, while the certification is based on an examination of relevant records and is neither an audit nor an expression of opinion on financial viability.